Report: Life sciences firm Dexcom to lay off almost 200 San Diego workers
It’s another set of layoffs for the company, located in Sorrento Valley. The firm specializes in technology for glucose biosensing.



One set of corporate cutbacks appear to have led to another, with San Diego jobs on the chopping block.
According to a Tuesday report by the San Diego Union-Tribune, Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego.
The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing, the Union-Tribune reported.
It’s another set of layoffs for the company, located in Sorrento Valley, which let more than 500 workers go last year, according to various media reports.
Dexcom, in its a Forbes profile, states that it employs more than 10,000 people. The firm was founded in 1999. Among the products sold by Dexcom are the G7 and Stelo systems and sensors, which offer varying levels of glucose monitoring.
The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google’s corporate parent.
According to Business Insider, Verily on Monday announced the shuttering of its devices program, which is perhaps where Dexcom comes in.
Verily’s work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.”
A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.”